Immunization with glycosylated Kb‐binding peptides generates carbohydrate‐specific, unrestricted cytotoxic T cells
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Cytotoxic T cells (CTL) recognize target proteins as short peptides presented by major histocompatibility complex (MHC) class I restriction elements. However, there is also evidence for peptide‐independent T cell receptor (TCR) recognition of target proteins and non‐protein structures. How such T cell responses are generated is presently unclear. We generated carbohydrate (CHO)‐specific, MHC‐unrestricted CTL responses by coupling di‐ and trisaccharides to K b‐ or D b‐binding peptides for direct immunization in mice. Four peptides and three CHO have been analyzed with the CHO either in terminal or central positions on the carrier peptide. With two of these glycopeptides, with galabiose (Galα1‐4Gal; Gal 2) bound to a homocysteine (via an ethylene spacer arm) in position 4 or 6 in a vesicular stomatitis virus nucleoprotein‐derived peptide (RGYVYQGL binding to K b), CTL were generated which preferentially killed target cells treated with glycopeptide compared to those treated with the core peptide. Polyclonal CTL were also found to kill target cells expressing the same Gal 2 epitope in a glycolipid. By fractionation of CTL, preliminary data indicate that glycopeptide‐specific K b‐restricted CTL and unrestricted CHO‐specific CTL belong to different T cell populations with regard to TCR expression. The results demonstrate that hapten‐specific unrestricted CTL responses can be generated with MHC class I‐binding carrier peptides. Different models that might explain the generation of such responses are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“If the peptide carries a very small glycan, this moiety can contribute novel speci fi city to recognition (587 -591).”
From Biological roles of glycans (2017) · cites this paper as [588]
Citations
Cites
The Biochemistry and Cell Biology of Antigen Processing and Presentation
Germain, R. (1993) · Annual Review of Immunology · doi:10.1146/annurev.immunol.11.1.403 · Cited by 1,020
Natural and synthetic non-peptide antigens recognized by human γδ T cells
Tanaka, Y., Morita, C. T., Tanaka, Y., Nieves, E., Brenner, M. B., & Bloom, B. R. (1995) · Nature · doi:10.1038/375155a0 · Cited by 1,013
Recognition of a lipid antigen by CD1-restricted αβ+ T cells
Beckman, E. M., Porcelli, S. A., Morita, C. T., Behar, S. M., Furlong, S. T., & Brenner, M. B. (1994) · Nature · doi:10.1038/372691a0 · Cited by 978
Empty MHC class I molecules come out in the cold
Ljunggren, H.-G., Stam, N. J., Öhlén, C., Neefjes, J. J., Höglund, P., Heemels, M.-T., Bastin, J., Schumacher, T. N. M., Townsend, A., Kärre, K., et al. (1990) · Nature · doi:10.1038/346476a0 · Cited by 926
Crystal Structures of Two Viral Peptides in Complex with Murine MHC Class I H-2K b
Fremont, D. H., Matsumura, M., Stura, E. A., Peterson, P. A., & Wilson, L. A. (1992) · Science · doi:10.1126/science.1323877 · Cited by 861
Haas, W., Pereira, P., & Tonegawa, S. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.003225 · Cited by 807
Peptides Naturally Presented by MHC Class I Molecules
Rammensee, H. G., Falk, K., & Rötzschke, O. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001241 · Cited by 799
Stimulation of Human γδ T Cells by Nonpeptidic Mycobacterial Ligands
Constant, P., Davodeau, F., Peyrat, M.-A., Poquet, Y., Puzo, G., Bonneville, M., & Fournié, J.-J. (1994) · Science · doi:10.1126/science.8146660 · Cited by 711
Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule
Bleek, G. M. V., & Nathenson, S. G. (1990) · Nature · doi:10.1038/348213a0 · Cited by 679
CDR3 length in antigen-specific immune receptors.
Rock, E. P., Sibbald, P. R., Davis, M. M., & Chien, Y. H. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.1.323 · Cited by 510
Research works printed but not linked: 4
- 10.1146/annurev.iy.11.040193.002155 · doi:10.1146/annurev.iy.11.040193.002155 · Paper page
- Zhao X.‐J., 1995, J. Exp. Med., 187, 64
- Fung P. Y. S., 1990, Cancer Res., 50, 4308
- Magnusson G., 1994, Complex Carbohydrates in Drug Research., 89
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“If the peptide carries a very small glycan, this moiety can contribute novel specificity to recognition (587) (588) (589) (590) (591) .”
BackgroundGlycosylation and the Immune System
Rudd, P. M., Elliott, T., Cresswell, P., Wilson, I. A., & Dwek, R. A. (2001) · Science · doi:10.1126/science.291.5512.2370 · Cited by 1,588
Concepts and Principles of O-Linked Glycosylation
Steen, P. V. D., Rudd, P. M., Dwek, R. A., & Opdenakker, G. (1998) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409239891204198 · Cited by 760
Avci, F. Y., Li, X., Tsuji, M., & Kasper, D. L. (2011) · Nature Medicine · doi:10.1038/nm.2535 · Cited by 366
MHC Class I–Restricted CTL Responses to Exogenous Antigens
Jondal, M., Schirmbeck, R., & Reimann, J. (1996) · Immunity · doi:10.1016/s1074-7613(00)80255-1 · Cited by 253
Self-citationPosttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens
Utz, P. J., & Anderson, P. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199807)41:7<1152::aid-art3>3.0.co;2-l · Cited by 209
Corthay, A., Bäcklund, J., Broddefalk, J., Michaëlsson, E., Goldschmidt, T. J., Kihlberg, J. O., & Holmdahl, R. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199808)28:08<2580::aid-immu2580>3.0.co;2-x · Cited by 173
Self-citationLigand recognition by the γδ TCR and discrimination between homeostasis and stress conditions
Deseke, M., & Prinz, I. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0503-y · Cited by 168
Recent Advance in Tumor-associated Carbohydrate Antigens (TACAs)-based Antitumor Vaccines
Feng, D., Shaikh, A. S., & Wang, F. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00084 · Cited by 166
The role of glycosylation in protein antigenic properties
Lisowska, E. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8437-3 · Cited by 130
Glithero, A., Tormo, J., Haurum, J. S., Arsequell, G., Valencia, G., Edwards, J. H., Springer, S., Townsend, A., Pao, Y., Wormald, M. R., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80007-2 · Cited by 127
Specificity in cancer immunotherapy
Schietinger, A., Philip, M., & Schreiber, H. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2008.07.001 · Cited by 105
“[68] Abdel-Motal UM, Berg L, Rosen A, Bengtsson M, Thorpe CJ, Kihlberg J, et al.”
BackgroundRecent Development in Carbohydrate Based Anticancer Vaccines
Yin, Z., & Huang, X. (2012) · Journal of Carbohydrate Chemistry · doi:10.1080/07328303.2012.659364 · Cited by 124
“3a) produced Tc cells that specifically killed cells presenting either the glycopeptide or the glycolipid with same carbohydrate moiety.[49] Furthermore, the Tc cells generated by RGY8-6H-Gal2 could also kill target cells pulsed with glycopeptide ASN9-6H-Gal2 (Fig.”
BackgroundCrystal Structure of an MHC Class I Presented Glycopeptide that Generates Carbohydrate-Specific CTL
Speir, J. A., Abdel‐Motal, U. M., Jondal, M., & Wilson, I. A. (1999) · Immunity · doi:10.1016/s1074-7613(00)80006-0 · Cited by 124
Self-citationVaccination with carbohydrate peptide mimotopes promotes anti-tumor responses
Kieber‐Emmons, T., Luo, P., Qiu, J., Chang, T. Y., O‐Sullivan, I., Blaszczyk‐Thurin, M., & Steplewski, Z. (1999) · Nature Biotechnology · doi:10.1038/10870 · Cited by 121
Martin, S. F. (2004) · International Archives of Allergy and Immunology · doi:10.1159/000078765 · Cited by 119
Carbohydrates and T cells: A sweet twosome
Avci, F. Y., Li, X., Tsuji, M., & Kasper, D. L. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.05.005 · Cited by 118
A glycopeptide in complex with MHC class I uses the GalNAc residue as an anchor
Apostolopoulos, V., Yuriev, E., Ramsland, P. A., Halton, J., Osinski, C., Li, W., Plebanski, M., Paulsen, H., & McKenzie, I. F. C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2432220100 · Cited by 97
Carbohydrates as T-cell antigens with implications in health and disease
Sun, L., Middleton, D. R., Wantuch, P. L., Ozdilek, A., & Avci, F. Y. (2016) · Glycobiology · doi:10.1093/glycob/cww062 · Cited by 101
“These carbohydrate-specific CTLs were MHCI unrestricted and could kill the target cells presenting the same carbohydrate on a different MHCI allele (Abdel-Motal et al. 1996).”
BackgroundInfluentialDendritic Cells in Antifungal Immunity and Vaccine Design
Roy, R. M., & Klein, B. S. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.04.005 · Cited by 99
“Immunization with glycosylated peptides was able to generate carbohydrate-specific CTL responses (Abdel-Motal et al., 1996), suggesting that appropriately designed glycoconjugates may be processed and crosspresented to CD8 T cells.”
Novel sequential solid-phase synthesis of N-linked glycopeptides from natural sources
Meinjohanns, E., Meldal, M., Paulsen, H. M., Dwek, R. A., & Bock, K. (1998) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/a705528e · Cited by 95
Making the most of mucin: a novel target for tumor immunotherapy
Barratt‐Boyes, S. M. (1996) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050315 · Cited by 90
“Furthermore, MHC-unrestricted T cells, specific for a carbohydrate moiety on glycosylated peptides, have been generated in vitro [1].”
BackgroundExtended O-GlcNAc on HLA Class-I-Bound Peptides
Marino, F., Bern, M., Mommen, G. P. M., Leney, A. C., van Gaans-van den Brink, J. A. M., Bonvin, A. M. J. J., Becker, C., van Els, C. A. C. M., & Heck, A. J. R. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b06586 · Cited by 79
The effect of haptens on protein‐carrier immunogenicity
Gefen, T., Vaya, J., Khatib, S., Rapoport, I., Lupo, M., Barnea, E., Admon, A., Heller, E. D., Aizenshtein, E., & Pitcovski, J. (2014) · Immunology · doi:10.1111/imm.12356 · Cited by 75
Designer Glycopeptides for Cytotoxic T Cell–based Elimination of Carcinomas
Xu, Y., Gendler, S. J., & Franco, A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031865 · Cited by 66
“One study that characterized the immunogenicity of designer glycopeptides modified a TcR contact(s) within a viral epitope described the induction of non-MHC class I–restricted CTL (47).”
BackgroundCarbohydrate Moieties as Vaccine Candidates
Lucas, A. H., Apicella, M. A., & Taylor, C. E. (2005) · Clinical Infectious Diseases · doi:10.1086/432582 · Cited by 61
“Cytotoxic T cell responses to carbohydrate antigens can be induced by immunization with either naturally occurring or synthetic glycopeptides [62, 63].”
BackgroundTumor-Associated Glycans and Immune Surveillance
Monzavi‐Karbassi, B., Pashov, A. D., & Kieber‐Emmons, T. (2013) · Vaccines · doi:10.3390/vaccines1020174 · Cited by 60
“It has been suggested that glycopeptide-specific-restricted CTL and unrestricted glycan-specific CTL belong to different T-cell populations with regard to TCR expression [95].”
BackgroundProcessing of glycans on glycoprotein and glycopeptide antigens in antigen-presenting cells
Werdelin, O., Meldal, M., & Jensen, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152345899 · Cited by 58
Carbohydrates and antigen recognition by T cells
Carbone, F., & Gleeson, P. A. (1997) · Glycobiology · doi:10.1093/glycob/7.6.725-d · Cited by 58
Synthetic methods of glycopeptide assembly, and biological analysis of glycopeptide products
Meldal, M., & Hilaire, P. M. S. (1997) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(97)80052-x · Cited by 55
State of the Art in Tumor Antigen and Biomarker Discovery
Even-Desrumeaux, K., Baty, D., & Chames, P. (2011) · Cancers · doi:10.3390/cancers3022554 · Cited by 52
“T cells [66-73].”
Thomsen-Friedenreich Antigen: The “Hidden” Tumor Antigen
Goletz, S., Cao, Y., Danielczyk, A., Ravn, P., Schöber, U., & Karsten, U. R. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0065-0_10 · Cited by 50
Blander, J. M., Ciborowski, P. S., Hsia, S., Watkins, S. C., & Finn, O. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3111 · Cited by 49
Czerwiński, M., Siemaszko, D., Siegel, D. L., & Spitalnik, S. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.9.4406 · Cited by 43
Phosphoantigen Presentation to TCR γδ Cells, a Conundrum Getting Less Gray Zones
Libero, G. D., Lau, S.-Y., & Mori, L. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00679 · Cited by 43
“Another study described mouse γδ cells recognizing glycosylated peptides in which MHC class I-bound peptides with two or three sugars were stimulatory (35).”
BackgroundT Cell Receptor and Function Cosegregate in Gamma-Delta T Cell Subsets
O’Brien, R. L., Lahn, M., Born, W. K., & Huber, S. A. (2001) · KARGER eBooks · doi:10.1159/000058829 · Cited by 40
Immunization with a carbohydrate mimicking peptide augments tumor-specific cellular responses
Monzavi‐Karbassi, B., Cunto-Amesty, G., Luo, P., Shamloo, S., Blaszczyk‐Thurin, M., & Kieber‐Emmons, T. (2001) · International Immunology · doi:10.1093/intimm/13.11.1361 · Cited by 38
Wierzbicki, A. J., Gil, M., Ciesielski, M. J., Fenstermaker, R. A., Kaneko, Y., Rokita, H., Lau, J. T. Y., & Kozbor, D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6644 · Cited by 37
“Other investigators have demonstrated induction of carbohydrate-specific unrestricted CTL responses with MHC class I-binding carrier peptides (33).”
BackgroundDeck, M. B., Sjölin, P., Unanue, E. R., & Kihlberg, J. O. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4740 · Cited by 36
Self-citationPurcell, A. W., & Gorman, J. J. (2001) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00361-6 · Cited by 35
A Mimic of Tumor Rejection Antigen-Associated Carbohydrates Mediates an Antitumor Cellular Response
Monzavi‐Karbassi, B., Luo, P., Jousheghany, F., Torres-Quiñones, M., Cunto-Amesty, G., Artaud, C., & Kieber‐Emmons, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1532 · Cited by 35
Kihlberg, J. O., Elofsson, M., & Salvador, L. A. (1997) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(97)89050-7 · Cited by 29
Self-citationSun, S., Zheng, X., Huo, C., Song, C., Li, Q., & Ye, X. (2016) · ChemMedChem · doi:10.1002/cmdc.201600094 · Cited by 27
Response of Murine γδ T Cells to the Synthetic Polypeptide Poly-Glu50Tyr50 1
Cady, C. T., Lahn, M., Vollmer, M., Tsuji, M., Seo, S. J., Reardon, C. L., O’Brien, R. L., & Born, W. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.1790 · Cited by 27
Malmström, V., Bäcklund, J., Jansson, L., Kihlberg, J. O., & Holmdahl, R. (2000) · Arthritis Research & Therapy · doi:10.1186/ar106 · Cited by 27
Self-citationCarbohydrate-Mimetic Peptides for Pan Anti-Tumor Responses
Kieber‐Emmons, T., Saha, S., Pashov, A. D., Monzavi‐Karbassi, B., & Murali, R. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00308 · Cited by 26
“However, it is also possible to generate carbohydrate-specific unrestricted CTL responses with MHC class-I-binding carrier peptides (74) that might explain the GD2 response (71).”
BackgroundCurrent Concepts in Cancer Vaccine Strategies
Monzavi‐Karbassi, B., & Kieber‐Emmons, T. (2001) · BioTechniques · doi:10.2144/01301dd02 · Cited by 25
Purcell, A. W., Chen, W., Ede, N. J., Gorman, J. J., Fecondo, J. V., Jackson, D. C., Zhao, Y., & McCluskey, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1085 · Cited by 25
Muthukkumar, S., & Stein, K. E. (2003) · Vaccine · doi:10.1016/j.vaccine.2003.08.047 · Cited by 24
Induction of cellular immunity by anti-idiotypic antibodies mimicking GD2 ganglioside
Basak, S. K., Birebent, B., Purev, E., Somasundaram, R., Maruyama, H., Žaloudík, J., Swoboda, R., Strittmatter, W., Li, W., Luckenbach, A., et al. (2003) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-002-0340-0 · Cited by 24
“Induction of cellular immunity by carbohydrates themselves is a controversial issue, although several studies have convincingly demonstrated carbohydrate reactivity of the induced T cells [ 1 , 16, 31, 39, 47, 55].”
Tissue distribution, antigen specificity and effector functions of γδ T cells in human diseases
Libero, G. D. (2000) · Springer Seminars in Immunopathology · doi:10.1007/s002810000043 · Cited by 24
Strategies in cancer vaccines development
Cunto-Amesty, G., Monzavi‐Karbassi, B., Luo, P., Jousheghany, F., & Kieber‐Emmons, T. (2003) · International Journal for Parasitology · doi:10.1016/s0020-7519(03)00054-7 · Cited by 24
Bengtsson, M., Broddefalk, J., Dahmén, J., Henriksson, K., Kihlberg, J. O., Lönn, H., Srinivasa, B. R., & Stenvall, K. (1998) · Glycoconjugate Journal · doi:10.1023/a:1006988810800 · Cited by 23
Self-citationMoffett, S., Shiao, T. C., Mousavifar, L., Mignani, S. M., & Roy, R. (2020) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1659 · Cited by 22
Sjölin, P., George, S. K., Bergquist, K., Roy, S., Svensson, A., & Kihlberg, J. O. (1999) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/a900435a · Cited by 22
Self-citationBridging Innate and Adaptive Antitumor Immunity Targeting Glycans
Pashov, A. D., Monzavi‐Karbassi, B., Raghava, G. P. S., & Kieber‐Emmons, T. (2010) · BioMed Research International · doi:10.1155/2010/354068 · Cited by 20
“It has been suggested that glycopeptide-specific-restricted CTL and unrestricted glycan-specific CTL belong to different T cell populations with regard to TCR expression [70].”
BackgroundČudić, M., Ertl, H. C. J., & Ötvös, L. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00388-7 · Cited by 20
The Sweet Side of Tumor Immunotherapy
Freire, T., & Osinaga, E. (2012) · Immunotherapy · doi:10.2217/imt.12.58 · Cited by 19
Does Antigen Glycosylation Impact the HIV-Specific T Cell Immunity?
Olvera, À., Cedeño, S., Llano, A., Mothe, B., Sánchez, J., Arsequell, G., & Brander, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.573928 · Cited by 19
Monzavi‐Karbassi, B., Cunto-Amesty, G., Luo, P., Lees, A., & Kieber‐Emmons, T. (2001) · Biologicals · doi:10.1006/biol.2001.0307 · Cited by 19
Apostolopoulos, V. (2001) · Frontiers in bioscience · doi:10.2741/a683 · Cited by 17
Noncanonical peptides in complex with MHC class I
Apostolopoulos, V., & Lazoura, E. (2004) · Expert Review of Vaccines · doi:10.1586/14760584.3.2.151 · Cited by 15
Antigen presentation of post‐translationally modified peptides in major histocompatibility complexes
de Wit, A. S., Bianchi, F., & van den Bogaart, G. (2025) · Immunology & Cell Biology · doi:10.1111/imcb.12839 · Cited by 12
Role of inhibitory B cell co‐receptors in B cell self‐tolerance to non‐protein antigens*
Tsubata, T. (2022) · Immunological Reviews · doi:10.1111/imr.13059 · Cited by 12
MHC-Restricted T Cell Responses against Posttranslationally Modified Peptide Antigens
Kastrup, I. B., Andersen, M. H., Elliott, T. J., & Haurum, J. S. (2001) · Advances in immunology · doi:10.1016/s0065-2776(01)78006-6 · Cited by 12
Influence of saccharide size on the cellular immune response to glycopeptides
Mogemark, M., Cirrito, T. P., Sjölin, P., Unanue, E. R., & Kihlberg, J. O. (2003) · Organic & Biomolecular Chemistry · doi:10.1039/b301747h · Cited by 12
Self-citationHudrisier, D., Riond, J., Mazarguil, H., & Gairin, J. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105974200 · Cited by 11
George, S. K., Holm, B., Reis, C. A., Schwientek, T., Clausen, H., & Kihlberg, J. O. (2001) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/b009567m · Cited by 10
Self-citationChen, L., & Jondal, M. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2004.01426.x · Cited by 12
Self-citationPashov, A. D., Monzavi‐Karbassi, B., Raghava, G. P. S., & Kieber‐Emmons, T. (2007) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v27.i3.50 · Cited by 10
Loading of the Antigen‐Presenting Protein CD1d with Synthetic Glycolipids
Wallner, F. K., Chen, L., Moliner, A., Jondal, M., & Elofsson, M. (2004) · ChemBioChem · doi:10.1002/cbic.200300655 · Cited by 9
Self-citationGlycan-RNA: a new class of non-coding RNA
Li, X., Loh, T. J., Lim, J. J., Saw, P. E., & Liao, Y. (2022) · BIO Integration · doi:10.15212/bioi-2021-0032 · Cited by 6
“Through the classical MHC relative way, monosaccharide and disaccharide alterations of glycopeptides are recognized by CD8+ and CD4+ T cells [58, 59].”
BackgroundKoj, S., Ługowski, C., & Niedziela, T. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.120969 · Cited by 6
Naturally Presented MHC Ligands Carrying Glycans
Dengjel, J., & Stevanović, S. (2006) · Transfusion Medicine and Hemotherapy · doi:10.1159/000090194 · Cited by 6
Honda, S., Zhang, W., Kalergis, A. M., DiLorenzo, T. P., Wang, F., & Nathenson, S. G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4276 · Cited by 5
“Glycan-modified peptide-specific CTLs can be induced, and recognition is dependent upon the nature of the glycan (19, 20 ).”
BackgroundEven-Desrumeaux, K. (2012) · theses.fr (ABES) · doi:10.70675/79174383zb5d7z49bfz8244zb11187f08c8d · Cited by 5
The Influence of HIV Envelope Glycosylation on Adaptive Immune Response
Hioe, C. E., Kumar, R., & Hu, S. L. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8872-9_3 · Cited by 4
N-Glycosylated type II collagen peptides as therapeutic saccharide vaccines for rheumatoid arthritis
Liu, D., Liu, S., Hu, F., Li, Z., & Li, Z. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2023.108762 · Cited by 4
Activation of Murine Epidermal Vγ5/Vδ1-TCR+ T Cell Lines by Glu-Tyr Polypeptides
Seo, S. J., Lahn, M., Cady, C. T., Vollmer, M., O’Brien, R. L., Born, W. K., & Reardon, C. L. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01364.x · Cited by 2
Kieber‐Emmons, A., Monzavi‐Karbassi, B., & Kieber‐Emmons, T. (2020) · Wiley eBooks · doi:10.1002/9780470015902.a0000500.pub2 · Cited by 2
Exploiting Molecular Mimicry in Targeting Carbohydrate Antigens
Cunto-Amesty, G., & Kieber‐Emmons, T. (2014) · ASM Press eBooks · doi:10.1128/9781555818074.ch13 · Cited by 1
Oligosaccharide Epitope Diversity and Therapeutic Potential
Hounsell, E. F., & Renouf, D. V. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-5383-0_24 · Cited by 1
Maximizing Immune Responses to Carbohydrate Antigens on Breast Tumors
Kieber‐Emmons, T. (2002) · Defense Technical Information Center (DTIC) · doi:10.21236/ada411424
Processing and presentation of exogenous antigen by dendritic cells
Chen, L. (2006) · Figshare
Saw, P. E., & Song, E. (2025) · Springer eBooks · doi:10.1007/978-981-96-3041-7_10
Im, J. S. (1999) · UA Campus Repository (The University of Arizona)
MHC-UNRESTRICTED MUC1-SPECIFIC T CELL RECEPTOR FOR CANCER IMMUNOTHERAPY/GENE THERAPY
Alajez, N. M. (2003) · D-Scholarship@Pitt (University of Pittsburgh)
Silva, M. C. (2023) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/c5e0-gn13
Metadata
- Authors
- Abdel‐Motal, U. M., Berg, L., Rosén, A., Bengtsson, M., Thorpe, C. J., Kihlberg, J., Dahmén, J., Magnusson, G., Karlsson, K., & Jondal, M.
- Affiliations
- Karolinska Institutet (SE)
- Linköping University (SE)
- Lund University (SE)
- University of Gothenburg (SE)
- Corresponding author
- Jondal, Mikael
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1996-04
- Volume
- 26
- Issue
- 3
- Pages
- 544-551
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2065961361
- Cited by
- 85
- References
- 43
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 1 · 2020: 3 · 2016: 4 · 2015: 2 · 2014: 3 · 2013: 3 · 2012: 3
- FWCI
- 2.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Keywords
- glycopeptides, glycolipid recognition, T cell receptor expression
- MeSH terms
- Amino Acid Sequence, Animals, Epitopes, Carbohydrate Sequence, Carbohydrates, Glycopeptides, Glycosylation, H-2 Antigens, Immunization, Lymphocyte Activation, Molecular Sequence Data, T-Lymphocytes, Cytotoxic, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.